Biotech startup ImmuneBridge unlocks cell therapy platform for partners, secures $7.7M seed extension
March 24, 2026San Francisco-based ImmuneBridge has announced a pivotal expansion: the company’s cell therapy screening and manufacturing platform, previously used only for its internal pipeline, will now be accessible to external therapeutic.
- 0
- 1,598 views